Estimating the Survival Impact of Not Receiving CAR T-cell (CAR T) Therapy When Eligible in Patients with Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) in the United States (US)

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Frederick Lundry Locke, Bradley Kievit, Genevieve Meier, Robert Blissett, Hil Hsu, Emily Boller, David Cobley, Markqayne D. Ray, Olalekan O. Oluwole
DOI: 10.1016/j.jtct.2025.12.537
Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Lymphoma Diagnosis and Treatment T-cell and B-cell Immunology

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S373–S374
Publication date
1 February 2026
Language
EN